Valuation Edwards Lifesciences Corporation
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 85.45 USD | +2.12% |
|
+0.76% | -0.28% |
Company Valuation: Edwards Lifesciences Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 80,883 | 46,128 | 46,246 | 43,663 | 49,471 | 48,183 | - | - |
| Change | - | -42.97% | 0.25% | -5.58% | 13.3% | -2.6% | - | - |
| Enterprise Value (EV) 1 | 80,616 | 45,956 | 45,198 | 40,285 | 45,843 | 44,687 | 43,173 | 41,407 |
| Change | - | -42.99% | -1.65% | -10.87% | 13.8% | -2.52% | -3.39% | -4.09% |
| P/E | 54.4x | 30.6x | 33.2x | 10.6x | 46.6x | 33.1x | 25.3x | 22.5x |
| PBR | 13.9x | 7.82x | 6.99x | 4.36x | 4.79x | 4.59x | 3.98x | 3.69x |
| PEG | - | 12.14x | -5.79x | 0x | -0.6x | 0.9x | 0.8x | 1.8x |
| Capitalization / Revenue | 15.5x | 8.57x | 7.7x | 8.03x | 8.15x | 7.13x | 6.49x | 5.89x |
| EV / Revenue | 15.4x | 8.54x | 7.53x | 7.41x | 7.56x | 6.61x | 5.81x | 5.06x |
| EV / EBITDA | 46.6x | 23.7x | 24.1x | 24.1x | 25.5x | 20.9x | 18.1x | 15.4x |
| EV / EBIT | 50.6x | 25.6x | 26.1x | 26.6x | 27.9x | 22.7x | 19.5x | 16.7x |
| EV / FCF | 57.3x | 47.2x | 47.9x | 139x | 34.3x | 52.6x | 26.8x | 22.8x |
| FCF Yield | 1.74% | 2.12% | 2.09% | 0.72% | 2.91% | 1.9% | 3.73% | 4.39% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 2.38 | 2.44 | 2.3 | 6.97 | 1.83 | 2.531 | 3.303 | 3.718 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 5,232 | 5,382 | 6,005 | 5,440 | 6,068 | 6,759 | 7,429 | 8,177 |
| EBITDA 1 | 1,729 | 1,936 | 1,879 | 1,670 | 1,800 | 2,137 | 2,383 | 2,687 |
| EBIT 1 | 1,594 | 1,796 | 1,734 | 1,514 | 1,644 | 1,971 | 2,212 | 2,484 |
| Net income 1 | 1,503 | 1,522 | 1,402 | 4,175 | 1,074 | 1,435 | 1,895 | 2,120 |
| Net Debt 1 | -267 | -172.7 | -1,048 | -3,378 | -3,628 | -3,496 | -5,010 | -6,775 |
| Reference price 2 | 129.55 | 74.61 | 76.25 | 74.03 | 85.25 | 83.68 | 83.68 | 83.68 |
| Nbr of stocks (in thousands) | 624,334 | 618,260 | 606,500 | 589,800 | 580,300 | 575,800 | - | - |
| Announcement Date | 26/01/22 | 31/01/23 | 06/02/24 | 11/02/25 | 10/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 32.54x | 6.61x | 20.93x | -.--% | 48.18B | ||
| 28.74x | 5.14x | 19.72x | 0.32% | 214B | ||
| 33.22x | 6.08x | 19.24x | 0.74% | 140B | ||
| 39.64x | 10.29x | 22.77x | -.--% | 128B | ||
| 16.48x | 3.47x | 11.19x | -.--% | 68.46B | ||
| 19.04x | 2.18x | 11.3x | 2.76% | 45.56B | ||
| 27.33x | 5.44x | 18.58x | 0.73% | 39.69B | ||
| 46.53x | 6.48x | 19.91x | -.--% | 37.69B | ||
| 19.73x | 5.19x | 13.32x | 1.16% | 30.14B | ||
| 41.17x | 6.5x | 23.12x | -.--% | 29.2B | ||
| Average | 30.44x | 5.74x | 18.01x | 0.57% | 78.09B | |
| Weighted average by Cap. | 30.83x | 6.06x | 18.80x | 0.46% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- EW Stock
- Valuation Edwards Lifesciences Corporation
Select your edition
All financial news and data tailored to specific country editions
















